Nuclear Lipid Microdomains Regulate Daunorubicin Resistance in Hepatoma Cells

Daunorubicin is an anticancer drug, and cholesterol is involved in cancer progression, but their relationship has not been defined. In this study, we developed a novel experimental model that utilizes daunorubicin, cholesterol, and daunorubicin plus cholesterol in the same cells (H35) to search for...

Descripción completa

Detalles Bibliográficos
Autores principales: Codini, Michela, Conte, Carmela, Cataldi, Samuela, Arcuri, Cataldo, Lazzarini, Andrea, Ceccarini, Maria Rachele, Patria, Federica, Floridi, Alessandro, Mecca, Carmen, Ambesi-Impiombato, Francesco Saverio, Beccari, Tommaso, Curcio, Francesco, Albi, Elisabetta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274808/
https://www.ncbi.nlm.nih.gov/pubmed/30388783
http://dx.doi.org/10.3390/ijms19113424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274808/
https://www.ncbi.nlm.nih.gov/pubmed/30388783
http://dx.doi.org/10.3390/ijms19113424

Ejemplares similares